Untreated metastatic diffuse gastric adenocarcinoma (DGAC): Randomized phase III study of S-1 and cisplatin vs. 5-FU and cisplatin (the DIGEST trial)
| العنوان: | Untreated metastatic diffuse gastric adenocarcinoma (DGAC): Randomized phase III study of S-1 and cisplatin vs. 5-FU and cisplatin (the DIGEST trial) |
|---|---|
| المؤلفون: | Fabio Benedetti, Vera Gorbunova, Jaime Feliu, Maria Alsina, Hontsa Anatoliy, Yaroslav Shparyk, Gerardo Rosati, Volodymyr Bondar, Udit Verma, Sergey Lazarev, Anneli Elme, Igor Bondarenko, Yuriy Vinnyk, Jaffer A. Ajani, Hirokazu Mizuguchi, Vivian Esko, Mikhail Abramov, Takekazu Aoyama, Kathia Cristina Abdalla, Lukas Makris |
| المصدر: | Journal of Clinical Oncology. 33:4015-4015 |
| بيانات النشر: | American Society of Clinical Oncology (ASCO), 2015. |
| سنة النشر: | 2015 |
| مصطلحات موضوعية: | Oncology, Cisplatin, Cancer Research, medicine.medical_specialty, Pathology, endocrine system diseases, business.industry, food and beverages, environment and public health, Gastric adenocarcinoma, First line therapy, Internal medicine, medicine, business, medicine.drug |
| الوصف: | 4015 Background: The prognosis for metastatic DGAC is poor but the first line therapy for patients (pts) with DGAC is the same as that of without DGAC. Analyses of the FLAGS study suggested that S-... |
| تدمد: | 1527-7755 0732-183X |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_________::1d5f55094e52d4584a0b601fac6f3d68Test https://doi.org/10.1200/jco.2015.33.15_suppl.4015Test |
| رقم الانضمام: | edsair.doi...........1d5f55094e52d4584a0b601fac6f3d68 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 15277755 0732183X |
|---|